China’s blue-chip shares closed lower on Tuesday (30) after US drugmaker Moderna raised new alarms about the Ômicron variant, while data showed that the service sector in the world’s second-largest economy grew at a pace slightly slower amid regional Covid-19 outbreaks.
The CSI300 index, which brings together the largest companies listed in Shanghai and Shenzhen, retreated 0.4%, while the Shanghai index was stable.
In the month, the CSI300 index fell 1.6%, while the Shanghai index rose 0.5%.
The Chinese papers weakened slightly after the head of drugmaker Moderna told the Financial Times that Covid-19 vaccines are unlikely to be as effective against the omicron variant of the coronavirus as they were against the delta variant.
Meanwhile, activity in China’s service sector grew at a slightly slower pace in November, as the sector was hit by new lockdown measures as authorities rushed to contain the latest outbreak of the disease.
In TOKYO, the Nikkei index retreated 1.63% to 27,821 points.
In HONG KONG, the HANG SENG index fell 1.58% to 23,475 points.
In SHANGHAI, the SSEC index gained 0.03% to 3,563 points.
The CSI300 index, which brings together the largest companies listed in SHANGHAI and SHENZHEN, retreated 0.40% to 4,832 points.
In SEUL, the KOSPI index had a devaluation of 2.42%, to 2,839 points.
In TAIWAN, the TAIEX index rose 0.58% to 17,427 points.
In SINGAPORE, the STRAITS TIMES index devalued 2.54% to 3,041 points.
In SYDNEY the S&P/ASX 200 index advanced 0.22% to 7,256 points.
Reference: CNN Brasil
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.
